About sectional interests meaning
secobarbital will decrease the extent or effect of cannabidiol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Carefully. Consider an increase in cannabidiol dosage (determined by medical response and tolerability) when coadministered with a strong CYP3A4 inducer.